Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Neuronetics Q1 EPS $(0.27) Beats $(0.34) Estimate, Sales $17.42M Beat $17.12M Estimate

Author: Benzinga Newsdesk | May 07, 2024 07:34am
Neuronetics (NASDAQ:STIM) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.31) by 12.9 percent. This is a 28.95 percent increase over losses of $(0.38) per share from the same period last year. The company reported quarterly sales of $17.42 million which beat the analyst consensus estimate of $17.12 million by 1.73 percent. This is a 12.08 percent increase over sales of $15.54 million the same period last year.

Posted In: STIM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist